5.36
price down icon0.46%   -0.03
after-market Handel nachbörslich: 5.36
loading
Schlusskurs vom Vortag:
$5.39
Offen:
$5.36
24-Stunden-Volumen:
434.57K
Relative Volume:
0.76
Marktkapitalisierung:
$1.20B
Einnahmen:
$596.48M
Nettoeinkommen (Verlust:
$123.72M
KGV:
9.7739
EPS:
0.5484
Netto-Cashflow:
$106.59M
1W Leistung:
-1.20%
1M Leistung:
+0.47%
6M Leistung:
+64.07%
1J Leistung:
+90.25%
1-Tages-Spanne:
Value
$5.35
$5.38
1-Wochen-Bereich:
Value
$5.35
$5.44
52-Wochen-Spanne:
Value
$2.37
$5.72

Curevac N V Stock (CVAC) Company Profile

Name
Firmenname
Curevac N V
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
1,088
Name
Twitter
Name
Nächster Verdiensttermin
2025-08-18
Name
Neueste SEC-Einreichungen
Name
CVAC's Discussions on Twitter

Vergleichen Sie CVAC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CVAC
Curevac N V
5.36 1.21B 596.48M 123.72M 106.59M 0.5484
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
412.22 104.45B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
469.36 60.95B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.60 59.11B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
812.95 49.23B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.94 35.92B 4.56B -176.77M 225.30M -1.7177

Curevac N V Stock (CVAC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-13 Herabstufung Jefferies Buy → Hold
2024-04-25 Herabstufung Leerink Partners Outperform → Market Perform
2023-06-08 Eingeleitet SVB Securities Outperform
2023-01-19 Hochstufung UBS Neutral → Buy
2023-01-09 Hochstufung Jefferies Hold → Buy
2022-01-21 Herabstufung BofA Securities Neutral → Underperform
2022-01-18 Eingeleitet JMP Securities Mkt Outperform
2021-10-22 Eingeleitet Deutsche Bank Hold
2021-06-17 Herabstufung BofA Securities Buy → Neutral
2021-04-26 Fortgesetzt Credit Suisse Underperform
2021-04-26 Eingeleitet Guggenheim Neutral
2020-12-10 Herabstufung Credit Suisse Neutral → Underperform
2020-09-08 Eingeleitet BofA Securities Buy
2020-09-08 Eingeleitet Credit Suisse Neutral
2020-09-08 Eingeleitet Jefferies Hold
Alle ansehen

Curevac N V Aktie (CVAC) Neueste Nachrichten

pulisher
05:53 AM

Will CureVac N.V. stock benefit from green energy trends2025 Breakouts & Breakdowns & Weekly Chart Analysis and Trade Guides - newser.com

05:53 AM
pulisher
05:28 AM

BioNTech secures German merger approval to buy CureVac - MLex

05:28 AM
pulisher
05:11 AM

Analyzing net buyer seller activity in CureVac N.V.2025 Price Action Summary & Community Driven Trade Alerts - newser.com

05:11 AM
pulisher
04:03 AM

Signal strength of CureVac N.V. stock in tech scannersEarnings Growth Report & Technical Pattern Recognition Alerts - newser.com

04:03 AM
pulisher
Oct 13, 2025

How interest rate cuts could boost CureVac N.V. stock2025 Geopolitical Influence & Accurate Buy Signal Alerts - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

Is CureVac N.V. trending in predictive chart models2025 Buyback Activity & Expert Approved Trade Ideas - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Can trapped investors hope for a rebound in CureVac N.V.2025 Breakouts & Breakdowns & Daily Profit Maximizing Trade Tips - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

How to build a dashboard for CureVac N.V. stock2025 Performance Recap & Weekly High Momentum Picks - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Pattern recognition hints at CureVac N.V. upsideJuly 2025 Intraday Action & Free Weekly Watchlist of Top Performers - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

Reversal indicators forming on CureVac N.V. stockTrade Ideas & Free Verified High Yield Trade Plans - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

CureVac (NASDAQ:CVAC) Earns "Hold (C-)" Rating from Weiss Ratings - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

How institutional ownership impacts CureVac N.V. stockJuly 2025 Trends & Community Consensus Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Sector ETF performance correlation with CureVac N.V.2025 Winners & Losers & Safe Swing Trade Setup Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Is CureVac N.V. stock reversal real or fake2025 Short Interest & Intraday High Probability Setup Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Will CureVac N.V. benefit from macro trendsCEO Change & Long-Term Capital Growth Strategies - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Real time breakdown of CureVac N.V. stock performanceJuly 2025 Analyst Calls & Real-Time Stock Price Movement Reports - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

Should you hold or exit CureVac N.V. nowTrade Ideas & Growth Focused Entry Reports - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Technical analysis overview for CureVac N.V. stockJuly 2025 Opening Moves & Intraday High Probability Alerts - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Technical signs of recovery in CureVac N.V.Weekly Earnings Recap & Low Drawdown Investment Strategies - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Can machine learning forecast CureVac N.V. recoveryWeekly Gains Summary & AI Optimized Trade Strategies - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

What MACD and RSI say about CureVac N.V.Weekly Earnings Recap & Expert Approved Trade Ideas - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

CureVac N.V. (NASDAQ:CVAC) Receives Consensus Rating of "Hold" from Analysts - MarketBeat

Oct 03, 2025
pulisher
Oct 03, 2025

How to manage a losing position in CureVac N.V.Market Movement Recap & Daily Profit Focused Stock Screening - newser.com

Oct 03, 2025
pulisher
Oct 01, 2025

Analyzing CureVac N.V. with risk reward ratio charts2025 Market WrapUp & Stepwise Trade Signal Guides - newser.com

Oct 01, 2025
pulisher
Oct 01, 2025

CureVac: The Hidden Value Of The mRNA Wallet - Seeking Alpha

Oct 01, 2025
pulisher
Sep 30, 2025

What Wall Street predicts for CureVac N.V. stock priceMarket Performance Report & Capital Protection Trading Alerts - newser.com

Sep 30, 2025

Finanzdaten der Curevac N V-Aktie (CVAC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.75
price down icon 5.47%
$85.96
price up icon 1.59%
$32.75
price up icon 0.41%
$102.61
price up icon 0.29%
$161.38
price down icon 1.45%
biotechnology ONC
$320.94
price down icon 1.85%
Kapitalisierung:     |  Volumen (24h):